Celldex Therapeutics (CLDX) Amortizatization of Intangibles (2016 - 2025)
Celldex Therapeutics has reported Amortizatization of Intangibles over the past 16 years, most recently at $882000.0 for Q4 2025.
- Quarterly results put Amortizatization of Intangibles at $882000.0 for Q4 2025, down 73.77% from a year ago — trailing twelve months through Dec 2025 was $5.9 million (down 62.82% YoY), and the annual figure for FY2025 was $5.9 million, down 62.82%.
- Amortizatization of Intangibles for Q4 2025 was $882000.0 at Celldex Therapeutics, down from $1.0 million in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for CLDX hit a ceiling of $4.7 million in Q2 2024 and a floor of -$772000.0 in Q1 2022.
- Median Amortizatization of Intangibles over the past 5 years was $1.2 million (2023), compared with a mean of $1.5 million.
- Biggest five-year swings in Amortizatization of Intangibles: skyrocketed 3617.24% in 2021 and later tumbled 1708.33% in 2022.
- Celldex Therapeutics' Amortizatization of Intangibles stood at -$198000.0 in 2021, then skyrocketed by 363.64% to $522000.0 in 2022, then surged by 317.43% to $2.2 million in 2023, then soared by 54.34% to $3.4 million in 2024, then plummeted by 73.77% to $882000.0 in 2025.
- The last three reported values for Amortizatization of Intangibles were $882000.0 (Q4 2025), $1.0 million (Q3 2025), and $1.7 million (Q2 2025) per Business Quant data.